» Articles » PMID: 34448037

Risk Factors and Clinical Outcomes for Placenta Accreta Spectrum with or Without Placenta Previa

Overview
Date 2021 Aug 27
PMID 34448037
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To clarify risk factors and clinical outcomes for placenta accreta spectrum (PAS) stratified by placenta previa.

Methods: We conducted registry-based multicenter cross-sectional study including 472,301 singleton deliveries between 2013 and 2015. PAS was considered as a primary outcome, as well as maternal age, parity, history of cesarean section, history of miscarriage, and assisted reproductive technology (ART) were considered as potential exposures. A multivariable Poisson regression analysis was conducted to assess the risk for PAS, stratified by placenta previa. In addition, the risk for subsequent blood transfusion and hysterectomy by each exposure using multivariable Poisson regression analysis was conducted.

Results: There were 426 and 1827 cases of PAS with and without placenta previa. Among cases with placenta previa, the number of previous cesarean sections was the most powerful predictor for PAS [adjusted risk ratio (aRR) for one previous cesarean section 5.34, 95% confidence interval (CI) 3.70-7.71; aRR for two or more previous cesarean section 16.5, 95% CI 11.5-23.6]. Among cases without placenta previa, previous cesarean section was not a significant predictor, whereas the strongest predictor was conception through ART (aRR 5.05, 95% CI 4.50-5.66). Although the risks of PAS for blood transfusion and hysterectomy were higher among cases with placenta previa, those without placenta previa also demonstrated non-negligible risks.

Conclusion: The current study demonstrated that history of cesarean section was the strongest risk factor for PAS among women with placenta previa. Among those without placenta previa, ART was an important predictor, but not cesarean section.

Citing Articles

Impact of Prior Cesarean Delivery on Pregnancy Outcomes and Hemorrhage Risks in Complete Placenta Previa: A Decade-Long Retrospective Analysis.

Wei X, Cheng W Med Sci Monit. 2024; 30:e944432.

PMID: 39552069 PMC: 11583507. DOI: 10.12659/MSM.944432.


Risk factors for non-previa placenta accreta spectrum in pregnancies conceived through frozen embryo transfer during a hormone replacement cycle in Japan.

Matsuo S, Kotani T, Tano S, Ushida T, Imai K, Nakamura T Reprod Med Biol. 2024; 23(1):e12592.

PMID: 39050787 PMC: 11266119. DOI: 10.1002/rmb2.12592.


Placental T2WI MRI-based radiomics-clinical nomogram predicts suspicious placenta accreta spectrum in patients with placenta previa.

Yu H, Yin H, Zhang H, Zhang J, Yue Y, Lu Y BMC Med Imaging. 2024; 24(1):146.

PMID: 38872133 PMC: 11177524. DOI: 10.1186/s12880-024-01328-y.


Assisted reproductive technology-associated risk factors for placenta accreta spectrum after vaginal delivery.

Jwa S, Tamaru S, Takamura M, Namba A, Kajihara T, Ishihara O Sci Rep. 2024; 14(1):7454.

PMID: 38548810 PMC: 10978827. DOI: 10.1038/s41598-024-57988-x.


Placenta Accreta Spectrum Diagnosis Challenges and Controversies in Current Obstetrics: A Review.

Arakaza A, Zou L, Zhu J Int J Womens Health. 2023; 15:635-654.

PMID: 37101719 PMC: 10124567. DOI: 10.2147/IJWH.S395271.


References
1.
Mhyre J, Shilkrut A, Kuklina E, Callaghan W, Creanga A, Kaminsky S . Massive blood transfusion during hospitalization for delivery in New York State, 1998-2007. Obstet Gynecol. 2013; 122(6):1288-94. PMC: 4547558. DOI: 10.1097/AOG.0000000000000021. View

2.
Goffman D, Nathan L, Chazotte C . Obstetric hemorrhage: A global review. Semin Perinatol. 2016; 40(2):96-8. DOI: 10.1053/j.semperi.2015.11.014. View

3.
Fitzpatrick K, Sellers S, Spark P, Kurinczuk J, Brocklehurst P, Knight M . Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One. 2013; 7(12):e52893. PMC: 3531337. DOI: 10.1371/journal.pone.0052893. View

4.
Silver R, Landon M, Rouse D, Leveno K, Spong C, Thom E . Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006; 107(6):1226-32. DOI: 10.1097/01.AOG.0000219750.79480.84. View

5.
Wu S, Kocherginsky M, Hibbard J . Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005; 192(5):1458-61. DOI: 10.1016/j.ajog.2004.12.074. View